Heron Therapeutics (HRTX) P/FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -4.36 | 0.00 | 0.00 | -9.62 | -7.77 | -3.80 | |||
| Changes by years, y/y, % | -57% | -100% | -19% | -5.0% | |||||
Heron Therapeutics. P/FCF
Heron Therapeutics. P/FCF, changes, %
Heron Therapeutics (HRTX) P/FCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/FCF | -14.2 | -10.8 | -6.89 | -7.77 | -7.27 | -3.80 | ||
| Changes by years, y/y, % | -78% | -20% | -49% | |||||
| Changes by quarters, q/q, % | +47% | -24% | -36% | +13% | -6% | |||